Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Research & Development (2023 - 2025)

Historic Research & Development for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $28.8 million.

  • Nuvation Bio's Research & Development rose 402.08% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.1 million, marking a year-over-year increase of 2927.87%. This contributed to the annual value of $99.1 million for FY2024, which is 3903.83% up from last year.
  • Latest data reveals that Nuvation Bio reported Research & Development of $28.8 million as of Q3 2025, which was up 402.08% from $27.4 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Research & Development peaked at $29.3 million during Q4 2024, and registered a low of $12.8 million during Q1 2024.
  • Moreover, its 3-year median value for Research & Development was $24.6 million (2025), whereas its average is $22.8 million.
  • As far as peak fluctuations go, Nuvation Bio's Research & Development plummeted by 3164.42% in 2024, and later skyrocketed by 9156.67% in 2025.
  • Quarter analysis of 3 years shows Nuvation Bio's Research & Development stood at $15.4 million in 2023, then surged by 90.86% to $29.3 million in 2024, then decreased by 1.55% to $28.8 million in 2025.
  • Its Research & Development stands at $28.8 million for Q3 2025, versus $27.4 million for Q2 2025 and $24.6 million for Q1 2025.